LB Pharmaceuticals Company Insiders
| LBRX Stock | 22.15 0.15 0.68% |
LB Pharmaceuticals employs about 16 people. The company is managed by 8 executives with a total tenure of roughly 38 years, averaging almost 4.0 years of service per executive, having 2.0 employees per reported executive. Break down of LB Pharmaceuticals' management performance can provide insight into the company performance.
LB Pharmaceuticals Management Team Effectiveness
Return On Tangible Assets is likely to drop to -1.98 in 2025. Return On Capital Employed is likely to rise to -2.42 in 2025. At this time, LB Pharmaceuticals' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 4.9 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 398.4 K in 2025. LB Pharmaceuticals' management efficiency ratios could be used to measure how well LB Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Common Stock Shares Outstanding is likely to drop to about 2.8 M in 2025
LB Pharmaceuticals Workforce Comparison
LB Pharmaceuticals Common is currently regarded as number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is now estimated at about 1,650. LB Pharmaceuticals maintains roughly 16.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.
LB Pharmaceuticals Common Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. LB Pharmaceuticals Common Price Series Summation is a cross summation of LB Pharmaceuticals price series and its benchmark/peer.
LB Pharmaceuticals Notable Stakeholders
A LB Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as LB Pharmaceuticals often face trade-offs trying to please all of them. LB Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting LB Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Zachary Prensky | Advisor Cofounder | Profile | |
| Heather JD | CEO Director | Profile | |
| Anna MD | Chief Officer | Profile | |
| Richard Silva | Senior Operations | Profile | |
| Kaya Panandiker | Chief Officer | Profile | |
| Gad Soffer | Chief Officer | Profile | |
| Marc CPA | Senior Finance | Profile | |
| James PharmD | Senior Affairs | Profile |
About LB Pharmaceuticals Management Performance
The success or failure of an entity such as LB Pharmaceuticals Common often depends on how effective the management is. LB Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of LBRX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the LBRX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.88) | (1.98) | |
| Return On Capital Employed | (2.55) | (2.42) | |
| Return On Assets | (1.88) | (1.98) | |
| Return On Equity | 0.67 | 0.36 |
Please note, the imprecision that can be found in LB Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LB Pharmaceuticals Common. Check LB Pharmaceuticals' Beneish M Score to see the likelihood of LB Pharmaceuticals' management manipulating its earnings.
LB Pharmaceuticals Workforce Analysis
Traditionally, organizations such as LB Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare LB Pharmaceuticals within its industry.LB Pharmaceuticals Manpower Efficiency
Return on LB Pharmaceuticals Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 3.9M | |
| Net Loss Per Executive | 7.9M | |
| Working Capital Per Employee | 1.3M | |
| Working Capital Per Executive | 2.6M |
Additional Tools for LBRX Stock Analysis
When running LB Pharmaceuticals' price analysis, check to measure LB Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LB Pharmaceuticals is operating at the current time. Most of LB Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of LB Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LB Pharmaceuticals' price. Additionally, you may evaluate how the addition of LB Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.